境内生产药品再注册申报程序、申报资料基本要求和审查要点(征求意见稿)

2020-08-13 国家药品监督管理局(NMPA) NMPA

境内生产药品再注册申报程序、申报资料基本要求和审查要点(征求意见稿)

中文标题:

境内生产药品再注册申报程序、申报资料基本要求和审查要点(征求意见稿)

发布日期:

2020-08-13

简要介绍:

境内生产药品再注册申报程序、申报资料基本要求和审查要点(征求意见稿)
境外生产药品再注册申报程序、申报资料要求和审查要点(征求意见稿)

相关资料下载:
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=021871c00258392e, title=境内生产药品再注册申报程序、申报资料基本要求和审查要点(征求意见稿), enTitle=, guiderFrom=NMPA, authorId=0, author=, summary=境内生产药品再注册申报程序、申报资料基本要求和审查要点(征求意见稿), cover=, journalId=0, articlesId=null, associationId=1683, associationName=国家药品监督管理局(NMPA), associationIntro=国家药品监督管理局(NMPA), copyright=0, guiderPublishedTime=Thu Aug 13 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>境内生产药品再注册申报程序、申报资料基本要求和审查要点(征求意见稿)<br />境外生产药品再注册申报程序、申报资料要求和审查要点(征求意见稿)</p>, tagList=[TagDto(tagId=459172, tagName=药品再注册)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=政策, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=30, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=309, appHits=1, showAppHits=0, pcHits=81, showPcHits=308, likes=0, shares=0, comments=0, approvalStatus=1, publishedTime=Tue Aug 09 14:55:51 CST 2022, publishedTimeString=2020-08-13, pcVisible=1, appVisible=1, editorId=0, editor=小小医者, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=小小医者, createdTime=Wed Aug 10 05:56:41 CST 2022, updatedBy=4754896, updatedName=小小医者, updatedTime=Wed Jan 03 12:51:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击:
评论区 (0)
#插入话题